Equity
€982,192 ▲ 0.1%
ENZYBEL PHARMA paid out €876,743 in dividends. That is 100% of the 2020 profit.
ENZYBEL PHARMA
Lifetime
4 annual accounts with figures on one time axispeak €1.1m (2020)
€1.1m▲ 8.2%
peak €877,786 (2020)
€877,786▲ 26.2%
peak €982,192 (2020)
€982,192▲ 0.1%
€1.6m▼ 41.8%
Board6 names since 2019
-
Owners2 names in the annual accounts
61.2%Natix and 1 other
Documentsfilings and deeds
01-07-202130 days before the deadline
2020financial year
Result from €695,576 to €877,7861 statutory auditor reappointed 28-07Debts from €2.7m to €1.6m
Key points
from the 2020 annual accounts, the last ones filedResult
€877,786 ▲ 26.2%
The result rose in 2020 from €695,576 to €877,786.
Filings
4 annual accounts since 2017
The last four annual accounts were filed 30 to 57 days before the end of the period.
No score
Board and ownership
- FLORIDIENNE SA consolidatesequity €777.6m (2025) · annual accounts 2020
Recent changes
Merger: absorbed by FLORINVEST
FLORINVEST holds all the shares · General meeting of 30-09-2021 · Gazette deed
Merger proposal: to be absorbed by FLORINVEST
Permanent representatives: Stefaan Van Daele and Thibaut Hofman · FLORINVEST holds all the shares · Board meeting of 25-03-2021 · Gazette deed
New statutory auditor
SC RSM Réviseurs d'Entreprises appointed, Mazars Réviseurs d'Entreprise SCRL resigned · Permanent representatives: Gert Van Leemput, Stefaan Vandaele and Thibaut Hofman · General meeting of 30-06-2021 · Gazette deed
1 director appointed, 1 resignation
Resignation: BIOTRAC SPRL · Appointment: T-I BV · Permanent representatives: Christian Van Osselaer, Stefaan Vandaele and Thibaut Hofman · General meeting of 19-04-2021 · Gazette deed
Official details
Source: KBO- Status
- Absorbed by FLORINVESTmerger by absorption, October 2021
- Activity
- “Principalement toutes activités se rapportant au sourcing et à la fabrication de produits et…” (deed in French)From the articles, 3 activitiesNo NACE code in the KBO yet
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Insights on ENZYBEL PHARMA
Absorbed by FLORINVEST in October 2021. The last annual accounts are for financial year 2020. The company was dissolved without liquidation. The books and records are kept by FLORINVEST.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about ENZYBEL PHARMA
- What is the company number of ENZYBEL PHARMA?
- The company number of ENZYBEL PHARMA is 0667.762.648. The VAT number is the same number with BE in front: BE 0667.762.648.
- What is the legal form of ENZYBEL PHARMA?
- Legal form of ENZYBEL PHARMA: SA.
- Is ENZYBEL PHARMA still active?
- No. ENZYBEL PHARMA is inactive in the KBO register.Company details
- What is the turnover of ENZYBEL PHARMA?
- The turnover in financial year 2020 is ≈ €1.8m. This figure is estimated from the gross margin of €1.1m and 1,585 comparable companies of the same size. It probably lies between €1.2m and €3.0m. It is a rough estimate.Financials
- Is ENZYBEL PHARMA profitable?
- In financial year 2020, ENZYBEL PHARMA made a profit of €877,786.
- Where can I find the annual accounts of ENZYBEL PHARMA?
- ENZYBEL PHARMA filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2020.